| PERIOD ENDING | 25-Sep-09 | 26-Jun-09 | 27-Mar-09 | 31-Dec-08 | | Total Revenue | 286,612 | 279,201 | 264,602 | 314,544 | | Cost of Revenue | 93,686 | 93,588 | 94,029 | 96,844 | | | Gross Profit | 192,926 | 185,613 | 170,573 | 217,700 | | | Operating Expenses | | Research Development | 70,097 | 64,981 | 58,190 | 73,900 | | Selling General and Administrative | 56,332 | 53,679 | 60,659 | 65,480 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 66,497 | 66,953 | 51,724 | 78,320 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 740 | 1,717 | 3,378 | 14,040 | | Earnings Before Interest And Taxes | 67,237 | 68,670 | 55,102 | 92,360 | | Interest Expense | 1,225 | 1,321 | 1,338 | 4,456 | | Income Before Tax | 66,012 | 67,349 | 53,764 | 87,904 | | Income Tax Expense | 9,308 | 19,926 | 9,803 | 4,863 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 56,704 | 47,423 | 43,961 | 83,041 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 56,704 | 47,423 | 43,961 | 83,041 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $56,704 | $47,423 | $43,961 | $83,041 |
|
0.51% Nasdaq 
Income Statement
